Matthieu Monge

2.6k total citations · 1 hit paper
36 papers, 1.4k citations indexed

About

Matthieu Monge is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthieu Monge has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthieu Monge's work include Blood Pressure and Hypertension Studies (8 papers), Electrolyte and hormonal disorders (4 papers) and 3D Printing in Biomedical Research (4 papers). Matthieu Monge is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Electrolyte and hormonal disorders (4 papers) and 3D Printing in Biomedical Research (4 papers). Matthieu Monge collaborates with scholars based in France, Netherlands and Belgium. Matthieu Monge's co-authors include Pierre Ronco, Cécile Legallais, Éric Leclerc, Jérôme Rossert, Bruno Fouqueray, B. Mougenot, Pierre‐Marie Girard, Jean‐Luc Meynard, David Verhelst and Michel Azizi and has published in prestigious journals such as The Lancet, Blood and Scientific Reports.

In The Last Decade

Matthieu Monge

33 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial

2015 329 citations Michel Azizi, Marc Sapoval et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthieu Monge France	15	422	372	261	203	175	36	1.4k
Mohammad Ali Canada	14	437 1.0×	338 0.9×	343 1.3×	88 0.4×	53 0.3×	27	1.1k
Lei Gao China	26	770 1.8×	333 0.9×	414 1.6×	222 1.1×	60 0.3×	110	1.8k
Marcello Rattazzi Italy	25	410 1.0×	666 1.8×	120 0.5×	109 0.5×	23 0.1×	99	2.0k
Päivi Lakkisto Finland	20	534 1.3×	191 0.5×	176 0.7×	33 0.2×	44 0.3×	56	1.2k
Andrew Salmon United Kingdom	22	425 1.0×	184 0.5×	108 0.4×	46 0.2×	59 0.3×	34	1.7k
Sistiana Aiello Italy	22	376 0.9×	407 1.1×	91 0.3×	28 0.1×	53 0.3×	45	1.9k
Benjamin Funke Germany	15	372 0.9×	185 0.5×	113 0.4×	53 0.3×	23 0.1×	24	1.4k
Heather A. Corkrey United States	7	282 0.7×	226 0.6×	51 0.2×	226 1.1×	57 0.3×	8	1.3k
Xiaopeng Li United States	16	473 1.1×	197 0.5×	123 0.5×	122 0.6×	49 0.3×	43	1.5k

Countries citing papers authored by Matthieu Monge

Since Specialization

Citations

This map shows the geographic impact of Matthieu Monge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Monge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Monge more than expected).

Fields of papers citing papers by Matthieu Monge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthieu Monge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Monge. The network helps show where Matthieu Monge may publish in the future.

Co-authorship network of co-authors of Matthieu Monge

This figure shows the co-authorship network connecting the top 25 collaborators of Matthieu Monge. A scholar is included among the top collaborators of Matthieu Monge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthieu Monge. Matthieu Monge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monge, Matthieu, et al.. (2023). Can the Realization of an External Wirsungostomy be an Option for High‐Risk Pancreatic Anastomosis After Pancreaticoduodenectomy?. World Journal of Surgery. 47(6). 1533–1539. 1 indexed citations

Moutel, Grégoire, et al.. (2022). Methodological and ethical quality of surgical trials from 2016 to 2020. Langenbeck s Archives of Surgery. 407(8). 3793–3802. 2 indexed citations

Bataille, Pierre, Hubert de Boysson, P. Cathébras, et al.. (2022). Antineutrophil Cytoplasm Antibody–Associated Vasculitides Valvular Impairment: Multicenter Retrospective Study and Systematic Review of the Literature. The Journal of Rheumatology. 49(12). 1349–1355. 1 indexed citations

Monge, Matthieu, M. Siebelt, Karin Koekkoek, et al.. (2018). Chronic kidney failure mineral bone disorder leads to a permanent loss of hematopoietic stem cells through dysfunction of the stem cell niche. Scientific Reports. 8(1). 15385–15385. 6 indexed citations

Monge, Matthieu, et al.. (2016). Dose-effect relationship of perindopril 10, 14 and 20 mg assessed by urine and plasma AcSDKP levels in mildly sodium-depleted healthy volunteers. International Journal of Cardiology. 222. 648–653. 2 indexed citations

Bijkerk, Roel, Coen van Solingen, Hetty C. de Boer, et al.. (2015). Silencing of MiRNA-126 in Kidney Ischemia Reperfusion is Associated with Elevated SDF-1 Levels and Mobilization of Sca-1+/Lin- Progenitor Cells. MicroRNA. 3(3). 144–149. 12 indexed citations

Blanchard, Anne, Rosa Vargas‐Poussou, Marion Vallet, et al.. (2014). Indomethacin, Amiloride, or Eplerenone for Treating Hypokalemia in Gitelman Syndrome. Journal of the American Society of Nephrology. 26(2). 468–475. 62 indexed citations

Okada, Takuya, Olivier Pellerin, Sébastien Savard, et al.. (2014). Eligibility for Renal Denervation: Anatomical Classification and Results in Essential Resistant Hypertension. CardioVascular and Interventional Radiology. 38(1). 79–87. 25 indexed citations

Jacques, Sébastien, et al.. (2012). Transcriptomic analysis of the effect of ifosfamide on MDCK cells cultivated in microfluidic biochips. Genomics. 100(1). 27–34. 23 indexed citations

10.

Monge, Matthieu, et al.. (2012). Thrombotic thrombocytopenic purpura due to anti-ADAMTS13 antibodies in multiple myeloma. Clinical Nephrology. 81(3). 210–215. 16 indexed citations

11.

Paullier, Patrick, et al.. (2011). Investigation into modification of mass transfer kinetics by acrolein in a renal biochip. Toxicology in Vitro. 25(5). 1123–1131. 19 indexed citations

12.

Monge, Matthieu, Dominique Chauveau, C. Cordonnier, et al.. (2011). Localized Amyloidosis of the Genitourinary Tract. Medicine. 90(3). 212–222. 24 indexed citations

13.

Letourneur, Franck, Philippe Chafey, Cédric Broussard, et al.. (2011). Analysis of transcriptomic and proteomic profiles demonstrates improved Madin–Darby canine kidney cell function in a renal microfluidic biochip. Biotechnology Progress. 28(2). 474–484. 49 indexed citations

14.

Solingen, Coen van, Leonard Seghers, Roel Bijkerk, et al.. (2008). Antagomir‐mediated silencing of endothelial cell specific microRNA‐126 impairs ischemia‐induced angiogenesis. Journal of Cellular and Molecular Medicine. 13(8a). 1577–1585. 222 indexed citations

15.

Shahapuni, I., Matthieu Monge, Roxana Oprisiu, et al.. (2006). Drug Insight: renal indications of calcimimetics. Nature Clinical Practice Nephrology. 2(6). 316–325. 9 indexed citations

16.

Monge, Matthieu, I. Shahapuni, Roxana Oprisiu, et al.. (2006). Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients. Nature Clinical Practice Nephrology. 2(6). 326–336. 13 indexed citations

17.

Coppo, Paul, Agnès Veyradier, & Matthieu Monge. (2006). Purpura thrombotique thrombocytopénique acquis idiopathique. La Presse Médicale. 35(12). 1876–1886. 3 indexed citations

18.

Shahapuni, I., Roxana Oprisiu, Matthieu Monge, et al.. (2005). Viewpoint: How Do Calcimimetics Fit Into the Management of Parathyroid Hormone, Calcium, and Phosphate Disturbances in Dialysis Patients?. Seminars in Dialysis. 18(3). 226–238. 18 indexed citations

19.

Presne, Claire, Matthieu Monge, Janette Mansour, et al.. (2004). Thérapeutique diurétique. 1(3). 73–111.

20.

Monge, Matthieu, et al.. (1996). Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition. Glia. 18(1). 39–48. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact